We are live on
!
Find out more
ProShares Ultra NASDAQ Biotechnology
8 hedge funds and large institutions have $1.82M invested in ProShares Ultra NASDAQ Biotechnology in 2013 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
BIB Hedge Fund Activity: Q2 2013 in Review
8 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q2 2013, worth a combined $1.82M.
Buyers outnumbered sellers: 8 funds opened new BIB positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
- 8 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.82M of ProShares Ultra NASDAQ Biotechnology stock for Q2 2013.
- 8 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q2 2013 and 0 closed out, a net change of +8 holders.
Based on aggregated 13F filings for Q2 2013.